There have been 50 recent insider transactions recorded for Spruce Biosciences, Inc. (SPRB), including 20 buys and 27 sells. Total insider buying was valued at $677.67K and total insider selling at $8.74M.
Notable insiders with recent activity include Hooks Corwin Dale, Szwarcberg Javier B., Gharib Samir M.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — SPRB
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-09 |
Hooks Corwin Dale |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-09 |
Hooks Corwin Dale |
Chief Commercial Officer |
RSU Award |
11,000 |
- |
- |
11,000 |
| 2025-12-31 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU Award |
4,690 |
$4.53 |
$21.25K |
19,004 |
| 2025-12-15 |
Gharib Samir M. |
President and CFO |
Option Exercise (Sell) |
496 |
- |
- |
497 |
| 2025-12-15 |
Szwarcberg Javier B. |
Chief Executive Officer |
Option Exercise (Sell) |
1,480 |
- |
- |
1,480 |
| 2025-12-11 |
Ways Douglas Kirk |
Interim Chief Medical Officer |
Return of Shares |
400 |
$169.50 |
$67.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Option Exercise (Sell) |
1,900 |
- |
- |
5,700 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Tax Withholding of RSU |
2,194 |
$88.41 |
$193.97K |
12,998 |
| 2025-12-11 |
Spiegelman Daniel K |
Director |
Return of Shares |
458 |
$564.00 |
$258.31K |
- |
| 2025-12-11 |
Grey Michael G |
Executive Chairman |
Return of Shares |
387 |
$108.00 |
$41.8K |
- |
| 2025-12-11 |
Gharib Samir M. |
President and CFO |
Return of Shares |
733 |
$1,506.00 |
$1.1M |
- |
| 2025-12-11 |
Simpson Camilla V |
Director |
Return of Shares |
173 |
$108.00 |
$18.68K |
- |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
Return of Shares |
10,000 |
$344.25 |
$3.44M |
- |
| 2025-12-11 |
Barretto-ko Percival |
Director |
Return of Shares |
800 |
$169.50 |
$135.6K |
- |
| 2025-12-11 |
Walbert Keli |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-12-11 |
Walbert Keli |
Director |
RSU Award |
3,400 |
$88.41 |
$300.59K |
3,400 |
| 2025-12-11 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU Award |
1,666 |
$104.13 |
$173.48K |
1,666 |
| 2025-12-10 |
Gharib Samir M. |
President and CFO |
Option Exercise (Sell) |
514 |
- |
- |
1,539 |
| 2025-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Option Exercise (Sell) |
1,196 |
- |
- |
3,588 |
| 2025-10-20 |
Gharib Samir M. |
President and CFO |
Option Exercise (Sell) |
2,053 |
- |
- |
- |
| 2025-10-20 |
Szwarcberg Javier B. |
Chief Executive Officer |
Option Exercise (Sell) |
4,784 |
- |
- |
- |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
1,051 |
| 2025-10-06 |
Parkman Healthcare Partners Llc |
10 Percent Owner |
Informative Sell |
25 |
$17.46 |
$436.39 |
1,050 |
| 2025-07-23 |
Ways Kirk |
Interim Chief Medical Officer |
RSU Award |
30,000 |
$0.12 |
$3.71K |
30,000 |
| 2025-07-22 |
Spiegelman Daniel K |
Director |
RSU Award |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Grey Michael G |
Executive Chairman |
RSU Award |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Aynechi Tiba |
Director |
RSU Award |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Muralidhar Bali |
Director |
RSU Award |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Simpson Camilla V |
Director |
RSU Award |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2025-07-22 |
Barretto-ko Percival |
Director |
RSU Award |
30,000 |
$0.12 |
$3.49K |
30,000 |
| 2024-12-16 |
Gharib Samir M. |
President and CFO |
Option Exercise (Sell) |
37,250 |
- |
- |
74,500 |
| 2024-12-16 |
Szwarcberg Javier B. |
Chief Executive Officer |
Option Exercise (Sell) |
111,000 |
- |
- |
222,000 |
| 2024-12-16 |
Charlton Ralph William Iii |
Chief Medical Officer |
Option Exercise (Sell) |
31,750 |
- |
- |
63,500 |
| 2024-12-10 |
Gharib Samir M. |
President and CFO |
Option Exercise (Sell) |
154,000 |
- |
- |
154,000 |
| 2024-12-10 |
Szwarcberg Javier B. |
Chief Executive Officer |
Tax Withholding of RSU |
128,020 |
$0.54 |
$68.75K |
338,101 |
| 2024-12-10 |
Charlton Ralph William Iii |
Chief Medical Officer |
Option Exercise (Sell) |
106,400 |
- |
- |
106,400 |
| 2024-05-22 |
Spiegelman Daniel K |
Director |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Grey Michael G |
Executive Chairman |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Aynechi Tiba |
Director |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Muralidhar Bali |
Director |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Simpson Camilla V |
Director |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Ways Kirk |
Director |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-05-22 |
Barretto-ko Percival |
Director |
RSU Award |
30,000 |
$0.75 |
$22.53K |
30,000 |
| 2024-03-21 |
Novo Holdings A/s |
10 Percent Owner |
Informative Sell |
465,021 |
$0.75 |
$350.95K |
2,550,000 |
| 2024-03-20 |
Novo Holdings A/s |
10 Percent Owner |
Informative Sell |
359,979 |
$0.73 |
$264.08K |
3,015,021 |
| 2024-03-19 |
Novo Holdings A/s |
10 Percent Owner |
Informative Sell |
593,000 |
$0.76 |
$447.72K |
3,375,000 |
| 2024-03-18 |
Novo Holdings A/s |
10 Percent Owner |
Informative Sell |
842,020 |
$0.77 |
$647.01K |
3,968,000 |
| 2024-03-14 |
Novo Holdings A/s |
10 Percent Owner |
Informative Sell |
1,912,316 |
$0.89 |
$1.7M |
4,810,020 |
| 2024-03-14 |
Gharib Samir M. |
President and CFO |
RSU Award |
154,000 |
- |
- |
154,000 |
| 2024-03-14 |
Szwarcberg Javier B. |
Chief Executive Officer |
RSU Award |
358,800 |
- |
- |
358,800 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
